Posts Tagged ‘cancer trial’
According to a new cancer trial, a harmless human virus that naturally occurs in the human body may be able to improve the effectiveness of two chemotherapy drugs in certain cancer patients. Early stage trial data recently published by Clinical Cancer Research showed that RT3D or Reolysin, a new cancer drug developed by Oncolytics Biotech Inc, had promising results in its preclinical and clinical studies conducted at The Institute of Cancer Research (ICR) and the Royal Marsden Hospital. These two institutes are known worldwide for their expertise in clinical research assistant jobs. The drug is largely based on the reovirus type 3 Dearing that is found in most adult respiratory and gastrointestinal tracts.